SCHEMBL9596292

SCHEMBL9596292

CCC(F)(F)C(F)(F)C(F)(C(=O)O)c1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.39
HIF1A Q16665 1/20 0.39
CYP1A2 P05177 3/20 0.38
PTPN1 P18031 1/20 0.37
CYP2D6 P10635 1/20 0.37
ALDH1A1 P00352 4/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
POLB P06746 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KIF11 P52732 1/20 0.36
TACR1 P25103 1/20 0.36
MAPT P10636 2/20 0.36
TSHR P16473 2/20 0.36
DRD2 P14416 1/20 0.36
OPRM1 P35372 1/20 0.36
DRD3 P35462 1/20 0.36
KCNN4 O15554 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31181863 0.79 MAPT (0.44) CYP2C19HIF1ACYP1A2PTPN1CYP2D6
SCHEMBL29010075 0.79 CYP1A2 (0.45) CYP2C19HIF1ACYP1A2PTPN1CYP2D6
SCHEMBL8996234 0.76 PTPN1 (0.33) CYP1A2PTPN1ALDH1A1KIF11MAPT
SCHEMBL28059707 0.75 MAPT (0.47) CYP2C19HIF1ACYP1A2PTPN1CYP2D6
SCHEMBL8996134 0.74 PTGS2 (0.33) CYP1A2PTPN1ALDH1A1MAPTCES1
SCHEMBL29009831 0.74 CYP1A2 (0.48) CYP2C19HIF1ACYP1A2PTPN1CYP2D6
SCHEMBL4660655 0.74 CYP1A2 (0.48) CYP2C19HIF1ACYP1A2PTPN1CYP2D6
SCHEMBL4063599 0.73 CYP2C19 (0.44) CYP2C19HIF1ACYP1A2PTPN1CYP2D6
SCHEMBL31601722 0.73 HDAC6 (0.32) CYP1A2HTT
SCHEMBL1667160 0.72 CYP1A2 (0.48) CYP2C19HIF1ACYP1A2PTPN1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250361249-A1 SURFACE TREATMENT AGENT DAIKIN INDUSTRIES, LTD. (JP) 2025-11-27 US disclosed
EP-4644398-A1 SURFACE TREATMENT AGENT Daikin Industries, Ltd. (JP) 2025-11-05 EP disclosed
WO-2024172036-A1 SURFACE TREATMENT AGENT ダイキン工業株式会社 2024-08-22 WO disclosed
WO-1993015047-A1 AMINO ACID DERIVATIVES AS PAF ANTAGONISTS BRITISH BIO-TECHNOLOGY LIMITED (GB) 1993-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250361249-A1 SURFACE TREATMENT AGENT ITGA1, ITGB1, GDI1 CYP2C19 1563/4885HIF1A 510/4885CYP1A2 679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.